Aditxt, Inc.
NASDAQ: ADTX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Amro A. Albanna
- Employees
- 26
- Headquarters
- Mountain View, United States
- IPO year
- 2020
- Market cap
- $318.0
- Website
- https://www.aditxt.com
Loading ADTX…
Loading profile data…Frequently asked questions about ADTX
What does Aditxt, Inc. (ADTX) do?
Aditxt, Inc. is a biotechnology firm dedicated to advancing immune system health through innovative mapping and reprogramming techniques. The company's developments include AditxtScore, a platform designed to empower individuals by providing insights into their immune profiles for better management and informed awareness of immune system attacks...
Where does ADTX trade?
Aditxt, Inc. (ADTX) trades on the NASDAQ Capital Market.
What sector is ADTX in?
Aditxt, Inc. (ADTX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Aditxt, Inc.?
Amro A. Albanna is the chief executive officer of Aditxt, Inc. (ADTX).
Where is Aditxt, Inc. headquartered?
Aditxt, Inc. is headquartered in United States.
Does ADTX pay a dividend?
Aditxt, Inc. (ADTX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ADTX go public?
Aditxt, Inc. (ADTX) completed its initial public offering in 2020.